In BC cells, MYC/MYCN-activated miR-9 was found to be a direct regulator of the CDH1 gene, and increased miR-9 levels were associated with metastatic status and local recurrence in BC patients [30,31]. The gene discussed is CDH1; the disease is breast cancer.